Guided Therapeutics, Inc.
GTHP
$0.1088
$0.00888.80%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 30.73% | 56.19% | 59.25% | 35.74% | 19.63% |
| Total Depreciation and Amortization | 11.76% | 10.71% | 11.11% | 15.79% | 18.06% |
| Total Amortization of Deferred Charges | -28.46% | -18.60% | -11.54% | -2.99% | -9.09% |
| Total Other Non-Cash Items | -93.45% | -102.19% | -99.00% | -55.98% | -22.20% |
| Change in Net Operating Assets | 1,055.24% | 647.56% | 410.73% | 114.47% | -119.16% |
| Cash from Operations | 35.91% | 35.79% | 40.52% | 25.13% | -18.05% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -15.78% | 29.19% | 38.06% | 54.02% | 23.70% |
| Issuance of Common Stock | 91.51% | 137.28% | -85.16% | -86.26% | -77.34% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -100.95% | -- | -- |
| Cash from Financing | 3,716.67% | 373.83% | -98.57% | -101.54% | -99.25% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 88.21% | 72.69% | -218.75% | -225.18% | -203.11% |